| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/24/1998 | US5840906 Forming anabaseine using nicotinyl piperidone salt |
| 11/24/1998 | US5840903 5-ht3 and 5-ht4 agonists and antagonists |
| 11/24/1998 | US5840900 High molecular weight polymer-based prodrugs |
| 11/24/1998 | US5840898 Method of removing heavy metal contaminants from organic compounds |
| 11/24/1998 | US5840896 Method of preventing or limiting reperfusion damage |
| 11/24/1998 | US5840891 Viricides with improved absorption |
| 11/24/1998 | US5840860 Delivering fatty acid to colon by linking fatty acid to a carbohydrate carrier |
| 11/24/1998 | US5840845 Senescent cell derived inhibitors of DNA synthesis |
| 11/24/1998 | US5840839 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| 11/24/1998 | US5840768 MCC: alginate pharmaceutical suspensions |
| 11/24/1998 | US5840767 Perfluorocarbons for biological gas exchange and method |
| 11/24/1998 | US5840766 Process for removing bile salts from a patient and compositions therefor |
| 11/24/1998 | US5840765 Depilating method |
| 11/24/1998 | US5840763 Treatment of a latent infection of herpes viruses |
| 11/24/1998 | US5840762 Administering zucapsaicin (cis-8-methyl-n-vanillyl-6-nonenamide) |
| 11/24/1998 | US5840761 Antiarrhythmia agents, inhibitors of the cellular na+/h+ antiporter |
| 11/24/1998 | US5840760 Organostannane modified polyvinyl alcohol |
| 11/24/1998 | US5840759 Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents |
| 11/24/1998 | US5840757 Lipid emulsion intended for parenteral or enteral feeding |
| 11/24/1998 | US5840756 Pharmaceutical composition of L-DOPA ester |
| 11/24/1998 | US5840755 Method and composition for topical therapy of headaches |
| 11/24/1998 | US5840754 Dosage form comprising oxybutynin |
| 11/24/1998 | US5840752 Cholesterol inhibitors and enzyme inhibitors for cosmetic hair removal |
| 11/24/1998 | US5840750 Discodermolide compounds |
| 11/24/1998 | US5840747 Calcium channel antagonists |
| 11/24/1998 | US5840746 Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
| 11/24/1998 | US5840745 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 11/24/1998 | US5840744 Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
| 11/24/1998 | US5840743 Modified benzimidazole nucleosides as antiviral agents |
| 11/24/1998 | US5840742 Pharmaceutical composition for inhibiting the growth of cancers |
| 11/24/1998 | US5840741 Arteriosclerosis depressant |
| 11/24/1998 | US5840739 Thiazoline acid derivatives |
| 11/24/1998 | US5840738 Selective β-3 adrenergic agonists |
| 11/24/1998 | US5840737 Carrier of bicarbonate of 1a metal; single dose |
| 11/24/1998 | US5840736 Methods and compositions for stimulating neurite growth |
| 11/24/1998 | US5840735 Estrogen |
| 11/24/1998 | US5840734 Use of tempol in the prevention of photoaging |
| 11/24/1998 | US5840731 Pain-alleviating drug composition and method for alleviating pain |
| 11/24/1998 | US5840729 Attenuating cognitive deficit |
| 11/24/1998 | US5840728 Viricides for treatment of herpes virus using cyclopropanated carbocyclic 2*-deoxynucleoside |
| 11/24/1998 | US5840727 (4-heteroaryl)-1- (2,3-dihydro-1H-isoindol-2-yl) alkyl! piperazines and related compounds and their therapeutic utility |
| 11/24/1998 | US5840726 Tachykinin receptor antagonists; useful in treating asthma, cough and bronchitis |
| 11/24/1998 | US5840725 Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 11/24/1998 | US5840723 Quinoxaline derivatives for treating tinnitus |
| 11/24/1998 | US5840722 Administering to inhibit endothelin receptors |
| 11/24/1998 | US5840721 Imidazole derivatives as MDR modulators |
| 11/24/1998 | US5840719 Apoptosis inhibitors for treating neurodegenerative diseases |
| 11/24/1998 | US5840717 Use of salysylic acid for regulating skin wrinkles and/or skin atrophy |
| 11/24/1998 | US5840714 Inclusion complexes of racemic ibuproxam and of optically active ibuproxam with cyclodextrin derivatives, pharmaceutical preparations containing said inclusion complexes and methods for using same |
| 11/24/1998 | US5840713 Therapy for tissue membrane insufficiency |
| 11/24/1998 | US5840712 Water soluble vitamin B12 receptor modulating agents and methods related thereto |
| 11/24/1998 | US5840708 Administering antisense oligonucleotide which hybridizes to expression controlling sequence of nucleic acid encoding dopamine receptor to inhibit production |
| 11/24/1998 | US5840707 A protein or peptide formulation comprising a polynucleotide component, a negatively charge lipid component and a divalent cation component |
| 11/24/1998 | US5840705 α-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed |
| 11/24/1998 | US5840702 Administering aminoglycoside antibiotic |
| 11/24/1998 | US5840701 Antiischemic agents and macomolecules |
| 11/24/1998 | US5840695 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 11/24/1998 | US5840683 Antitumor |
| 11/24/1998 | US5840673 Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of p53-related tumors |
| 11/24/1998 | US5840552 Using microorganisms or microbial enzyme system to produce stereospecific enantiomers; antiulcer agents |
| 11/24/1998 | US5840544 DNA encoding rantes homolog from prostate |
| 11/24/1998 | US5840540 Sequence determination and expression of familial alzheimer's disease membrane protein |
| 11/24/1998 | US5840538 Lgt |
| 11/24/1998 | US5840531 Expression of mammalian islet cell neogenesis associated protein; vectors, probes, antisense constructs |
| 11/24/1998 | US5840530 DNA encoding receptors for the beta-2 chain of human IL-12 |
| 11/24/1998 | US5840505 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells |
| 11/24/1998 | US5840504 Method for separating sex specific molecules and non-sex specific molecules |
| 11/24/1998 | US5840495 Methods for diagnosis of conditions associated with elevated levels of telomerase activity |
| 11/24/1998 | US5840491 DNA sequence encoding the Machado-Joseph disease gene and uses thereof |
| 11/24/1998 | US5840489 Diagnosis and treatment of supravalvular aortic stenosis and Williams syndrome |
| 11/24/1998 | US5840340 Oligopeptides with fragrance, cosmetics and dye |
| 11/24/1998 | US5840337 Gelling liquid polyethylene glycol at room temperature with calcium acetate |
| 11/24/1998 | US5840336 Two-phase matrix for sustained release drug delivery device |
| 11/24/1998 | US5840333 Process for the preparation of oral compositions containing quinolones |
| 11/24/1998 | US5840331 Use of γ-hydroxybutyrate for the stimulation of sleep-related secretion growth hormone and prolactin |
| 11/24/1998 | US5840330 Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained |
| 11/24/1998 | US5840328 Treatment using arachidonic acid metabolite and particulate formulations |
| 11/24/1998 | US5840301 Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors |
| 11/24/1998 | US5840299 Binding and treatment of multiple sclerosis |
| 11/24/1998 | US5840297 Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process |
| 11/24/1998 | US5840294 Method for treating amyloidosis |
| 11/24/1998 | US5840283 Composition and method for treating diseased nails |
| 11/24/1998 | US5840282 Light screening compositions |
| 11/24/1998 | US5840278 Nasal spray having a mineral vitamin component, a mineral component and aloe vera |
| 11/24/1998 | US5840277 Treatment of chronic pulmonary inflammation |
| 11/24/1998 | CA2159989C 8-substituted xanthines as selective adenosine receptor agents |
| 11/24/1998 | CA2159591C Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| 11/24/1998 | CA2155130C Xanthine derivatives as adenosine a1 receptor antagonists |
| 11/24/1998 | CA2108584C Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 11/24/1998 | CA2101267C Process for the production of a pyrogen-free fructan which is readily water-soluble as well as renal diagnostic agent containing such a fructan |
| 11/24/1998 | CA2082944C Pharmaceutical compositions |
| 11/24/1998 | CA2029705C Enzymatic resolution of endo-bicyclo¬2.2.1|heptan-2-ol and derived pharmaceutical agents |
| 11/24/1998 | CA2007181C Sustained release pharmaceutical composition |
| 11/23/1998 | CA2232809A1 Novel compounds |
| 11/23/1998 | CA2221837A1 A novel human gene similar to a secreted protein frizb (atg-1639) |
| 11/23/1998 | CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1 |
| 11/23/1998 | CA2206047A1 Immunomodulating compositions for the treatment of viral disorders |
| 11/22/1998 | CA2231017A1 A member of the frzb family, frazzled |
| 11/22/1998 | CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9 |
| 11/20/1998 | WO1998052549A2 Use of fumaric acid derivatives |